Liposomal Irinotecan Shows a Larger Therapeutic Index than Non-liposomal Irinotecan in Patient-Derived Xenograft Models of Pancreatic Cancer.
- Resource Type
- Article
- Source
- Oncology & Therapy; Mar2023, Vol. 11 Issue 1, p111-128, 18p
- Subject
PANCREATIC tumors DRUG efficacy BIOMARKERS XENOGRAFTS DRUG dosage ANIMAL experimentation IRINOTECAN TREATMENT effectiveness RATS CELL nuclei RESEARCH funding MICE DOGS PATIENT safety DRUG toxicity - Language
- ISSN
- 23661070